WHO calls for new ways to tackle AMR

14 July 2022

The World Health Organization has released a report on antimicrobial-resistant (AMR) bacterial pathogens. The analysis points to the need of accelerating vaccine development and maximizing current vaccines related to AMR.

The WHO prioritizes sixty-one vaccine candidates in various stages of clinical development in its report. Additionally, it stresses the need for global access to already existing vaccines.

‘Vaccine development is expensive, and scientifically challenging, often with high failure rates, and for successful candidates complex regulatory and manufacturing requirements require further time. We have to leverage the lessons of COVID vaccine development and speed up our search for vaccines to address AMR.’ said Dr. Kate O’Brien, Director Immunization, Vaccines and Biologicals Department at WHO.

Read the complete news report here.